Denise M: Precision Hemostasis in Patient Blood Management
Denise M, Bloodless Medicine and Surgery Program Coordinator, shared a post on LinkedIn:
“Sometimes the best work begins with a challenge.
A few weeks ago, I posted an infographic on the value of Patient Blood Management (PBM) during a crisis.
Tomaz Crochemore, critical care physician and hemostasis expert, left a comment that stopped me.
He said the infographic was outstanding.
Then he pushed further. He wanted to see Patient Clot Management and precision hemostatic medicine explicitly woven into the PBM framework.
It was the first time I had heard of Patient Clot Management. While the physiology of bleeding and thrombosis including conditions like DIC is familiar territory in clinical practice, the term Patient Clot Management was new to me.
Crochemore’s work gave language and structure to that complexity.
I visited his profile (who is this guy?), and found his just published article in the Juntendo Medical Journal:
‘Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine.’ That was my a-ha moment.
The dynamic balance between bleeding and thrombosis. Coagulopathy phenotyping. Individualized hemostatic therapy.
He was right. So I went to work.
What emerged is this:
Precision Hemostasis in Patient Blood Management.
A framework that moves beyond anemia and transfusion stewardship into the full spectrum of blood health:
- Identifying coagulopathy phenotypes — sepsis, trauma, cancer, obstetric, ECMO-induced
- Matching therapy to the patient’s actual hemostatic state
- Preventing both bleeding AND thrombosis
Not one-size-fits-all. Precision-guided. Patient at the center.
For me, it expanded how I think about the PBM framework and adds another dimension to the PBM conversation
Thank you, Crochemore, for seeing further and for trusting that a PBM nurse coordinator in Brooklyn would follow you there. It was great collaborating with you.
This infographic is proof. LinkedIn made it possible. ”

Stay updated with Hemostasis Today.
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America